Ovintiv's Keeps Sector Perform, US$54 Price Target at RBC Capital Markets Ahead of Q3
Ovintiv Maintained at Buy at Truist Ahead of Q3 Results; Price Target Kept at US$47.00
Truist Financial Maintains Ovintiv(OVV.US) With Buy Rating, Announces Target Price $47
Truist Financial Sticks to Their Buy Rating for Ovintiv (OVV)
Morgan Stanley Maintains Ovintiv(OVV.US) With Hold Rating, Maintains Target Price $51
Barclays Maintains Ovintiv(OVV.US) With Buy Rating, Maintains Target Price $53
Ovintiv Maintained at Buy at TPH Ahead of Q3 Results; Price Target at US$63.00
Jefferies Maintains Ovintiv(OVV.US) With Buy Rating, Cuts Target Price to $57
Mizuho Securities Maintains Ovintiv(OVV.US) With Buy Rating, Cuts Target Price to $58
Ovintiv (OVV) Receives a Rating Update From a Top Analyst
Mizuho Securities Maintains Ovintiv(OVV.US) With Buy Rating, Cuts Target Price to $58
Ovintiv Is Maintained at Outperform by Mizuho
Ovintiv Analyst Ratings
Ovintiv Inc. Is Maintained at Buy by Citigroup
Citi Maintains Ovintiv(OVV.US) With Buy Rating, Cuts Target Price to $55
Ovintiv Maintained at Buy at UBS Ahead of Third-Quarter Results; Price Target Kept at US$57.00
J.P. Morgan Maintains Ovintiv(OVV.US) With Buy Rating, Raises Target Price to $52
Barclays Maintains Ovintiv(OVV.US) With Buy Rating, Maintains Target Price $53
Barclays Maintains Ovintiv(OVV.US) With Buy Rating, Cuts Target Price to $53
Ovintiv Analyst Ratings
No Data
No Data